Loren Data's SAM Daily™

fbodaily.com
Home Today's SAM Search Archives Numbered Notes CBD Archives Subscribe
FBO DAILY - FEDBIZOPPS ISSUE OF FEBRUARY 12, 2014 FBO #4463
SOLICITATION NOTICE

A -- Chlamydia Trachomatis Vaccine Safety and Efficacy Evaluation in Nonhuman Primates

Notice Date
2/10/2014
 
Notice Type
Presolicitation
 
NAICS
541711 — Research and Development in Biotechnology
 
Contracting Office
Department of Health and Human Services, National Institutes of Health, National Institute of Allergy and Infectious Diseases, Office of Acquisitions, 6700 B Rockledge Room 3214 MSC7612, Bethesda, Maryland, 20892-7612
 
ZIP Code
20892-7612
 
Solicitation Number
NIAID-DMID-NIHAI2014003
 
Archive Date
2/25/2014
 
Point of Contact
Courtney A Nichols, Phone: 3014513689, George Kennedy, Phone: 301-451-2607
 
E-Mail Address
courtney.nichols@nih.gov, kennedyg@mail.nih.gov
(courtney.nichols@nih.gov, kennedyg@mail.nih.gov)
 
Small Business Set-Aside
N/A
 
Description
The NIAID intends to solicit a sole source contract with the University of Washington to perform a Chlamydia trachomatis vaccine safety and efficacy study. This contract is a follow-on to the Topical Microbicide Safety and Efficacy Evaluation in Nonhuman Primates contract (HHSN266200700013C). The purpose of this follow-on contract is to continue development of a Chlamydia STD vaccine by performing an efficacy study in pigtail macaques. This efficacy study follows the pathogenesis study currently being conducted under the contract with University of Washington. The NIAID seeks to test this vaccine for efficacy using the female pigtail macaque against sexually transmitted Chlamydia D/LC/P+ with an intact CT135 gene and plasmid to determine if a phase 1 clinical trial is appropriate. The University of Washington possesses the facilities, resources, expertise and access to pigtail macaques that make it uniquely qualified to perform this work. Additionally, the safety and efficacy study must be performed on specimens from the same source as those used for the pathogenesis study. Since the pathogenesis study is already underway at University of Washington, awarding the contract to another source would result in substantial duplication of costs. This procurement is being conducted in accordance with FAR 6.302-1. The unique services University of Washington can provide make it the only responsible source capable of supplying the services required by the NIAID. Award to any other source would result in substantial duplication of cost to the Government that is not expected to be recovered through competition. NIAID anticipates awarding a cost-type completion contract as a result of this announcement with a performance period of 9 months. This is not a request for proposals, proposal abstracts, or quotations and does not commit the Government to any contractual agreement. A Research and Development Sources Sought Notice was posted on November 4, 2013 as HHSN-NIH-NIAID-RDSS-14-NIHAI2014003. All responsible sources may submit a capability statement, proposal, or quotation, which shall be considered by the agency. The RFP will be available on or about February 25, 2014. Interested parties may contact the points of contact referenced in this announcement.
 
Web Link
FBO.gov Permalink
(https://www.fbo.gov/spg/HHS/NIH/NIAID/NIAID-DMID-NIHAI2014003/listing.html)
 
Record
SN03284800-W 20140212/140210234124-2f43584dd2a90d33a325629efcf457c7 (fbodaily.com)
 
Source
FedBizOpps Link to This Notice
(may not be valid after Archive Date)

FSG Index  |  This Issue's Index  |  Today's FBO Daily Index Page |
ECGrid: EDI VAN Interconnect ECGridOS: EDI Web Services Interconnect API Government Data Publications CBDDisk Subscribers
 Privacy Policy  Jenny in Wanderland!  © 1994-2024, Loren Data Corp.